Table 3.
Imaging techniques used to detect the main MEN1-associated tumors.
| Site | Tumor | Imaging |
|---|---|---|
| Pituitary | Pituitary tumors | MRI |
| Parathyroid glands | Parathyroid tumors | Neck US 99mTc-MIBI scintigraphy |
| C-11 Met-PET/CT | ||
| Chest | Bronchial and thymic carcinoid | MR ICT |
| Octreotide scintigraphy | ||
| Ga-68-DOTATOC-PET/CT | ||
| 18F-FDG PET/CT | ||
| GI tract | Gastrinoma | MRI |
| CT | ||
| EUS | ||
| SRS | ||
| Selective abdominal angiography | ||
| Ga-68-DOTATOC-PET/CT | ||
| Insulinoma | MRI | |
| CT | ||
| US/EUS | ||
| SRS | ||
| Celiac axis angiography | ||
| GLP-1 PET/TC | ||
| Other pNET | MRI | |
| CT | ||
| EUS | ||
| SRS | ||
| Ga-68-DOTATOC-PET/CT | ||
| 18F-FDG PET/CT | ||
| Non-functioning pNET | MRI | |
| CT | ||
| EUS | ||
| Adrenal | Adrenal tumors | MRI or CT |
CT, computed tomography; EUS, endoscopic ultrasonography; FDG, fluorodeoxyglucose; MIBI, methoxyisobutyl isonitrile; MRI, magnetic resonance imaging; PET, positron emission tomography; pNET, pancreatic neuroendocrine tumor; SRS, somatostatin receptor scintigraphy; ZES, Zollinger-Ellison syndrome; US, ultrasonography.